Eli Lilly (LLY.US) “lowers its stance” and partners with former rival Hims (HIMS.US) to compete for the self-paid weight loss drug market

智通财经2026/11/06 12:37

Show original

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

According to Zhitong Finance APP, Eli Lilly (LLY.US) is collaborating with Hims & Hers Health Inc. (HIMS.US), leveraging the telemedicine company’s large customer base to make its blockbuster weight loss drugs available to a wider audience and thereby boost sales of its medications, including the new oral weight loss drug Foundayo.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Eli Lilly (LLY.US) “lowers its stance” and partners with former rival Hims (HIMS.US) to compete for the self-paid weight loss drug market

You may also like

Crypto prices